GENEVA, March 19 -- COVANT THERAPEUTICS OPERATING, INC. (1111B S Governors Ave, STE 48073Dover, DE, 19904), MOORE, Keith P. (c/o Covant Therapeutics Operating, Inc.1111B S Governors Ave, STE 48073Dover, DE 19904), KURUKULASURIYA, Ravi (c/o Covant Therapeutics Operating, Inc.1111B S Governors Ave, STE 48073Dover, DE 19904), ROBINSON, Shaughnessy (c/o Covant Therapeutics Operating, Inc.1111B S Governors Ave, STE 48073Dover, DE 19904), CHRISTOPHER, Matthew (c/o Covant Therapeutics Operating, Inc.1111B S Governors Ave, STE 48073Dover, DE 19904), CULLEN, Matthew, D. (c/o Covant Therapeutics Operating, Inc.1111B S Governors Ave, STE 48073Dover, DE 19904), IMBRIGLIO, Jason (c/o Covant Therapeutics Operating, Inc.1111B S Governors Ave, STE 48073Dov...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.